Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- First Posted Date
- 2007-08-23
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 522
- Registration Number
- NCT00519753
- Locations
- 🇩🇪
Mainz, Mainz, Germany
Adherence Assessment With Travalert Dosing Aid
Phase 4
Completed
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2007-07-30
- Last Posted Date
- 2012-07-12
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 102
- Registration Number
- NCT00508469
- Locations
- 🇪🇸
Zaragoza, Zaragoza, Spain
A Clinical Study of Tobradex AF
Phase 3
Completed
- Conditions
- Cataract
- First Posted Date
- 2007-05-14
- Last Posted Date
- 2008-07-29
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 900
- Registration Number
- NCT00473070
- Locations
- 🇺🇸
Pittsburgh, Pittsburgh, Pennsylvania, United States
Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye
Phase 3
Completed
- Conditions
- Dry Eye
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2012-06-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 750
- Registration Number
- NCT00471419
- Locations
- 🇺🇸
Cleveland, Cleveland, Ohio, United States
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 46
- Registration Number
- NCT00471380
- Locations
- 🇮🇹
Catania, Catania, Italy
Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
Phase 4
Terminated
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2012-04-11
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 46
- Registration Number
- NCT00471068
- Locations
- 🇵🇹
Coimbra, Coimbra, Portugal
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
Phase 4
Completed
- Conditions
- Glaucoma
- First Posted Date
- 2007-05-03
- Last Posted Date
- 2012-05-25
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 30
- Registration Number
- NCT00468988
- Locations
- 🇺🇸
Orlando, Orlando, Florida, United States
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- First Posted Date
- 2007-04-25
- Last Posted Date
- 2008-07-29
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 150
- Registration Number
- NCT00465621
- Locations
- 🇺🇸
Atlanta, Atlanta, Georgia, United States
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2007-04-25
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 81
- Registration Number
- NCT00465803
- Locations
- 🇺🇸
Seattle, Seattle, Washington, United States
Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
Phase 2
Completed
- Conditions
- Open-angle Glaucoma
- Interventions
- Other: Anecortave Acetate Vehicle
- First Posted Date
- 2007-03-23
- Last Posted Date
- 2012-11-28
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 89
- Registration Number
- NCT00451152
- Locations
- 🇺🇸
Texas, San Antonio, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath